Enzo Biochem

Enzo Biochem is a company listed under the stock ticker ENZ (US).

View the org chart displaying its 9 main executives

Most searched biographies at Enzo Biochem

• Kara Cannon, Interim Chief Executive Officer
• Bradley Radoff, Director
• Mary Tagliaferri, Director

Popular executive movements at Enzo Biochem

• Patricia Eckert, who was Interim Chief Financial Officer, is promoted to Chief Financial Officer  (posted on February 2 2024).
• Steven Pully has joined the company as Director  (posted on October 31 2023).
• Hamid Erfanian, Chief Executive Officer, has left the company  (posted on September 7 2023).

Click here to view some more movements at Enzo Biochem

Create your alert
to follow the executive moves at Enzo Biochem.

Enzo Biochem has 1,810 competitors including Siemens Healthineers (Germany), IQVIA (United States (USA)) and Saint Francis Health System (United States (USA)).

Popular M&A news in Healthcare

• Two Chairs has just announced a $72 Million fundraising (posted on April 18 2024).
• Grow Therapy has just announced a $88 Million fundraising (posted on April 12 2024).
• SSI Strategy and NDA Group have announced they will merge  (posted on April 8 2024)..

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Ralph De La Torre - Chairman and Chief Executive Officer at Steward Health Care
• Sima Sistani - Chief Executive Officer and Director at WW International

Learn more about the Healthcare industry >

Press releases by Enzo Biochem

• Press Releases | Enzo Biochem
• Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test Under FDA’s Emergency Use Authorization | Enzo Biochem
• Enzo Biochem’s Clinical Labs Subsidiary Launches Drive-Through Facility to Provide COVID-19 Testing on Long Island | Enzo Biochem
• Enzo Biochem Reports Fiscal Second Quarter Results | Enzo Biochem
• Enzo Biochem’s Full Service Clinical Laboratory to Launch Coronavirus (COVID-19) Testing Services Next Week | Enzo Biochem
• Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting | Enzo Biochem
• Regulatory role of SphK1 in TLR 7/9 – dependent type I interferon response and autoimmunity | Enzo Biochem
• Enzo Biochem Reports Publication of Study Detailing Promising Activity of Drug Candidate SK1‑I in a Model of Lupus | Enzo Biochem
• Enzo Biochem Announces Significant Milestone with Approval of Proprietary GenFlex Platform | Enzo Biochem
• Enzo Biochem Proposes to Increase Size of Board and Will Appoint Additional Highly Qualified, Diverse Independent Director in Near Future | Enzo Biochem
• View more press releases Close

Social media about Enzo Biochem

• Enzo Biochem on Wikipedia, Google News & Yahoo Finance
• Enzo Biochem on LinkedIn, Twitter & YouTube

Contact by email its executives including Kara Cannon

Call Enzo Biochem at +1 212...

View the org chart

Register to receive your alert

Report an error